Search

everythinglearnresearchcommunity

for

Search:↓

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

Illness perception affects mental health and quality of life in Chinese alopecia patients.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

People with Lichen Planopilaris tend to be more depressed, have lower self-esteem, and a worse quality of life.

Korean Red Ginseng may improve skin condition and reduce allergy markers in atopic dermatitis patients.

Tamoxifen caused hair loss in a 52-year-old woman.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Symmetrical Acrokeratoderma (SAK) may be a unique skin condition in China, lacking specific treatment and needing long-term monitoring.

Inhaled steroids in children may cause excessive hair growth and not always go away after stopping the medication.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

The flutamide-loaded hydrogel is a promising, skin-friendly treatment for acne and hair loss, potentially requiring less frequent application.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Adiponectin and bradykinin play important roles in skin health and may help treat skin conditions.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Tailoring COVID-19 measures to risk levels in the military improves health and readiness.

Eating vegetarian, having allergies, and family history might be linked to getting gray hair early.

Breathing in fine particles or Asian dust short-term doesn't affect schoolchildren's skin symptoms.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

Inconsistent safety reporting in chronic back pain trials risks patient safety and decision-making.

Adolescents with severe alopecia incur significantly higher healthcare costs.